Showing 30 of 3783 posts
Vertu Motors FY2025: £4.76bn revenue despite ZEV challenges. Resilient used cars & aftersales, £10m cost cuts. Key analysis here.
JoshuaMay 14, 2025
Spire Healthcare maintains 2025 targets with £30m efficiency drive and strategic NHS alliance. Stable growth meets cost discipline in UK healthcare sector.
JoshuaMay 14, 2025
AdvancedAdvT's strategic £5.3m HFX acquisition expands workforce SaaS reach, bridging SME-enterprise markets and boosting recurring revenue streams.
JoshuaMay 14, 2025
Imperial Brands reports strong half-year growth: tobacco resilience & NGP surge drive dividend hike and £1.25bn share buyback. Key insights for investors.
JoshuaMay 14, 2025
Gooch & Housego acquires Global Photonics in $17.5M strategic US defence expansion, boosting transatlantic photonics capabilities and defence sector growth.
JoshuaMay 14, 2025
Burberry's 94% profit plunge sparks major restructuring: 1,700 jobs cut, £100m savings plan. Can 'British Luxury' reboot revive the heritage brand?
JoshuaMay 14, 2025
Marston's H1 2025: Profit surge & debt slashed through strategic pub upgrades. Digital transformation drives 10.5% sales growth. Full-year confidence.
JoshuaMay 13, 2025
Angling Direct's FY25: Record £91.3m sales (+11.9%), MyAD loyalty driving 75% UK revenue & strategic European expansion. Profits leap as margins widen.
JoshuaMay 13, 2025
Macfarlane Group maintains 2025 outlook despite profit dip. Q1 sales up 14% & £4m buyback signal confidence in steady packaging growth.
JoshuaMay 13, 2025
Treatt's profits halve as citrus costs squeeze margins, but dividend holds firm amid sugar-reduction growth bets. Can H2 deliver the zing?
JoshuaMay 13, 2025
Restore PLC's strong trading update & 3 strategic UK acquisitions in public sector/shredding. See how expansion fuels profit growth.
JoshuaMay 13, 2025
Revolution Beauty FY25: Strategic shifts drive 26% revenue decline but cut inventory by half, target Gen Z growth. Risks remain with US tariffs & debt.
JoshuaMay 13, 2025
Renew H1 2025: 13% revenue surge to £569.3m & record £908m order book. 5.4% dividend hike. Strategic rail, water, energy moves amid sector challenges.
JoshuaMay 13, 2025
Diaceutics FY 2024: 39% revenue surge & 50% EBITDA jump. US expansion, PMx adoption & enterprise deals fuel precision medicine dominance. Path to profit clear.
JoshuaMay 13, 2025
On the Beach posts 23% adjusted profit rise and 13% TTV growth in H1 FY25, expands into Ireland & city breaks with tech-driven strategy.
JoshuaMay 13, 2025
IQE 2024: 88% EBITDA growth to £8.1m, new CEO Jutta Meier appointed amid strategic review & potential Taiwan semiconductor sale.
JoshuaMay 13, 2025
Wickes Group Q1 2025: Retail revenue up 9.6% on volume growth & TradePro success. Strategic expansions & market share gains analysed.
JoshuaMay 13, 2025
DCC PLC sells healthcare arm for £1.05bn, returns £800m to shareholders & pivots to energy growth. Key analysis inside.
JoshuaMay 13, 2025
Bytes Tech smashes £2bn revenue with 15% growth, Microsoft dominance & public sector deals driving record results. Special dividend sweetens FY25 triumph.
JoshuaMay 13, 2025
Malvern's 2024 results: 42% HE growth offsets 10% ELT decline. Strategic uni partnerships fuel expansion while London language schools struggle.
JoshuaMay 12, 2025
Tan Delta's FY 2024: Mixed results but £35m sales pipeline & strategic AI/OEM expansions signal transformative IoT potential. Can they convert?
JoshuaMay 12, 2025
FRP acquires One Advisory for £8.1m, expanding governance services and City presence with 41 specialists. 14th strategic move since 2020 IPO.
JoshuaMay 12, 2025
Victrex raises FY volume guidance on 16% H1 growth but faces China operational issues & margin pressures. Key analysis for investors.
JoshuaMay 12, 2025
Caledonia Mining's Q1 2025 smashes records: 493% net profit surge & 9.3% production growth. Solar asset sale & cost control fuel golden momentum.
JoshuaMay 12, 2025
Optima Health FY25: Strong growth, £210m MoD contract & strategic acquisitions. Insights on NHS partnerships and expansion moves.
JoshuaMay 12, 2025
IG Group forecasts FY25 revenue ≥£1.05bn & profit ≥£516m as volatility drives trading, with strategic buybacks and Freetrade integration progress.
JoshuaMay 12, 2025
Likewise Group FY24 Results: Revenue up 7.4%, margins expand as strategic hub network fuels progress toward £200m target.
JoshuaMay 12, 2025
MYCELX advances PFAS cleanup with DoD contract & Middle East deals. Strategic Saudi exit triples cash. Clean tech pivot fuels growth potential.
JoshuaMay 12, 2025
ITM Power's 300MW APAC electrolyser deal triples capacity, validating PEM tech & signalling green hydrogen's scalable future. Insights inside.
JoshuaMay 12, 2025
Iofina's 7th straight growth year: $54.5m revenue (+9%), 31% iodine derivatives surge & new Oklahoma plants. Analysis inside.
JoshuaMay 12, 2025